Dino Sangiamo litigates civil cases in state and federal courts across the United States. A substantial portion of his practice consists of litigation in the setting of the pharmaceutical industry, although it includes other commercial settings as well.

In the pharmaceutical setting, Mr. Sangiamo has served as regional and national counsel in both vaccine and drug products liability litigation. In addition to traditional case-specific litigation activities, his practice in this arena has included determining nationwide strategy, developing and implementing legal and factual defenses for use across cases, coordinating with other industry defendants, and managing company discovery, including defending company officials at deposition and developing approaches to large-scale document discovery. He also has assisted in proceedings before congressional committees, and consulting on public relations activities and other client business initiatives. Mr. Sangiamo's experience with numerous legal aspects of the vaccine industry also includes familiarity with national vaccine legislation and implications for industry of proceedings in Vaccine Court, where he has argued motions on behalf of a vaccine manufacturer. He has also assisted in developing regulatory compliance programs. Finally, Mr. Sangiamo has also served in a local counsel role in vaccine and medical device cases.

In other commercial settings, Mr. Sangiamo has handled a variety of litigation matters including both arbitrations and lawsuits. In recent years, these have consisted of several matters in the context of the defense industry, cutting-edge medical research, and enterprise software.

Significant Matters

• Representing a vaccine manufacturer in nationwide litigation concerning the allegation that a preservative in vaccines causes autism.
• Representing a manufacturer of a cholesterol-reducing drug in nationwide litigation concerning allegations of muscle and psychological injuries.
• Representing a vaccine manufacturer as intervenor in defense of a suit filed against the FDA for release of data previously submitted by the manufacturer to the government.
• Representing a vaccine manufacturer defending against efforts to issue subpoenas for manufacturer documents in Vaccine Court.
• Representing a vaccine manufacturer in protecting its confidential commercial information and trade secrets contained in documents produced by the government in proceedings in Vaccine Court.
• Representing a vaccine manufacturer in responding to congressional inquiries.

• Representing a prominent medical research institution and researcher in connection with claims of research fraud.
• Representing an information security company in connection with a dispute concerning use of encryption technology in the top-secret Type 1 market, and a related dispute involving the scope of copyright protection for that technology.
• Representing a defense and aerospace company in a dispute concerning termination of an overseas agent.
• Representing an enterprise software development company in multiple cases including termination of an overseas distributor, disputes over scope of licensing, claims of fraud regarding a joint development undertaking, and software warranty claims.